Page last updated: 2024-08-23

tetrahydrocannabivarin 9 and Schizophrenia

tetrahydrocannabivarin 9 has been researched along with Schizophrenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cascio, MG; Marini, P; Parolaro, D; Pertwee, RG; Zamberletti, E	1

Other Studies

1 other study(ies) available for tetrahydrocannabivarin 9 and Schizophrenia

Article	Year
The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects. British journal of pharmacology, 2015, Volume: 172, Issue:5 Topics: Animals; Antipsychotic Agents; Cannabinoids; CHO Cells; Cricetulus; Dronabinol; Male; Molecular Sequence Data; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Schizophrenia; Schizophrenic Psychology	2015

Article

Year

The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects.

British journal of pharmacology, 2015, Volume: 172, Issue:5

Topics: Animals; Antipsychotic Agents; Cannabinoids; CHO Cells; Cricetulus; Dronabinol; Male; Molecular Sequence Data; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Schizophrenia; Schizophrenic Psychology

2015